dc.contributor.author | Irfan, T | |
dc.contributor.author | Okines, A | |
dc.contributor.author | Khabra, K | |
dc.contributor.author | Ring, A | |
dc.contributor.author | Parton, M | |
dc.contributor.author | Johnson, S | |
dc.contributor.author | Turner, N | |
dc.date.accessioned | 2018-02-20T11:42:45Z | |
dc.date.issued | 2017-06-01 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402491900011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier.citation | CLINICAL ONCOLOGY, 2017, 29 (6), pp. E99 - E100 (5) | |
dc.identifier.issn | 0936-6555 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1387 | |
dc.identifier.eissn | 1433-2981 | |
dc.identifier.doi | 10.1016/j.clon.2017.01.021 | |
dc.format.extent | E99 - E100 (5) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCIENCE LONDON | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Oncology | |
dc.title | Clinical Benefit from Vinorelbine after Prior Treatment with Eribulin: a Single-centre Experience | |
dc.type | Other | |
rioxxterms.versionofrecord | 10.1016/j.clon.2017.01.021 | |
rioxxterms.licenseref.startdate | 2017-06-01 | |
rioxxterms.type | Other | |
dc.relation.isPartOf | CLINICAL ONCOLOGY | |
pubs.issue | 6 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 29 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Molecular Oncology | en_US |
dc.contributor.icrauthor | Turner, Nicholas | en |
dc.contributor.icrauthor | Marsden, | en |